Lyell Immunopharma, Inc.
USD12.89
+0.14 (+1.10%)
CEO
Lynn Seely
IPO Date
2021-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.79
Prev. Close
$12.75
Day Low
$12.41
Day High
$13.02
52W Low
$8.87
52W High
$45.00
Market Cap
$0.30B
Volume
0.02M
| -0.5 |
| 31 Dec 2023 | FY | 100.0% | -180486.2% | -35.8% | -31.3% | 0.10 | 16.07 | -2.1 |
| 31 Dec 2022 | FY | 100.0% | -216.2% | -22.0% | -19.5% | 0.08 | 17.59 | -4.7 |
| 31 Dec 2021 | FY | 100.0% | -2349.5% | -26.9% | -22.2% | 0.07 | 13.40 | -7.5 |
| 31 Dec 2020 | FY | 100.0% | -2636.3% | -28.5% | -22.5% | 0.08 | 12.53 | -20.4 |
| 31 Dec 2019 | FY | 100.0% | -19692.1% | -31.7% | -23.3% | 0.07 | 19.97 | -32.2 |
| -0.9 |
| 30 Sept 2025 | Q3 | 100.0% | -258973.3% | -11.8% | -9.5% | 0.13 | 10.30 | -1.9 |
| 30 Jun 2025 | Q2 | 100.0% | -533550.0% | -14.3% | -11.1% | 0.18 | 7.65 | -0.8 |
| 31 Mar 2025 | Q1 | 100.0% | -745642.9% | -15.5% | -12.1% | 0.17 | 7.49 | -0.8 |
| 31 Dec 2024 | Q4 | 100.0% | -1744863.6% | -50.1% | -39.1% | 0.15 | 7.06 | -0.2 |
| 30 Sept 2024 | Q3 | 100.0% | -131126.5% | -8.4% | -7.2% | 0.11 | 13.43 | -2.0 |
| 30 Jun 2024 | Q2 | 100.0% | -352376.9% | -8.1% | -7.0% | 0.11 | 16.19 | -2.2 |
| 31 Mar 2024 | Q1 | 100.0% | -2022233.3% | -10.1% | -8.7% | 0.10 | 16.51 | -2.3 |
| 31 Dec 2023 | Q4 | -38800.0% | -407153.8% | -8.1% | -7.1% | 0.10 | 16.07 | -2.3 |